---
schema_version: "secwatch.filing_event.v1"
accession: "0001773751-25-000248"
form_type: "8-K"
ticker: "HIMS"
cik: "0001773751"
company_name: "Hims & Hers Health, Inc."
filed_at: "2025-08-04T23:59:59+00:00"
generated_at: "2026-05-17T21:32:26.792213+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Hims & Hers Q2 rev $545M (+73%), net income $42.5M, reaffirms FY25

## Summary
- Revenue $544.8M (+73% YoY); net income $42.5M (vs $13.3M); Adj EBITDA $82.2M (vs $39.3M).
- Subscribers 2.44M (+31% YoY); monthly online revenue per subscriber $74 (+30% YoY).
- Gross margin 76% (down ~500 bps YoY); free cash flow -$69.4M (vs +$47.6M prior year).
- FY25 guidance reaffirmed: revenue $2.3-2.4B and Adj EBITDA $295-335M.
- Acquired ZAVA Global (European digital health); expects $50M+ revenue from ZAVA in H2 at positive EBITDA.

## SEC filing metadata
- accession: 0001773751-25-000248
- form_type: 8-K
- ticker: HIMS
- cik: 0001773751
- company_name: Hims & Hers Health, Inc.
- filed_at: 2025-08-04T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1773751/000177375125000248/0001773751-25-000248-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1773751/000177375125000248/hims-20250804.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001773751-25-000248
- JSON: https://secwatch.observer/filing/0001773751-25-000248.json
- Plain text: https://secwatch.observer/filing/0001773751-25-000248.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.